Recent Insider Transactions - Relmada Therapeutics (NASDAQ: RLMD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ RLMD Relmada Therapeutics

TRAVERSA SERGIO / director, officer: Chief Executive Officer

12/15/2025

Buy

$4.12

27,500

$113K

1.30M

NASDAQ RLMD Relmada Therapeutics

TRAVERSA SERGIO / director, officer: Chief Executive Officer

12/12/2025

Buy

$4.06

1.20M

$4.864M

1.20M

NASDAQ RLMD Relmada Therapeutics

Shenouda Maged / officer: Chief Financial Officer

12/12/2025

Buy

$4.06

828,000

$3.362M

828,000

NASDAQ RLMD Relmada Therapeutics

Shenouda Maged / officer: Chief Financial Officer

12/15/2025

Buy

$4.12

11,665

$48K

800,000

NASDAQ RLMD Relmada Therapeutics

Ence Chuck / officer: CA and CO

12/12/2025

Buy

$4.06

828,000

$3.362M

828,000

NASDAQ RLMD Relmada Therapeutics

Fedeli Fabiana / director

12/12/2025

Buy

$4.06

164,000

$666K

164,000

NASDAQ RLMD Relmada Therapeutics

GLASSPOOL JOHN / director

12/12/2025

Buy

$4.06

164,000

$666K

164,000

NASDAQ RLMD Relmada Therapeutics

Kelly Paul Edward / director, officer: COO

12/12/2025

Buy

$4.06

828,000

$3.362M

828,000

NASDAQ RLMD Relmada Therapeutics

CASAMENTO CHARLES J / director

12/12/2025

Buy

$4.06

164,000

$666K

164,000

NASDAQ RLMD Relmada Therapeutics

Shenouda Maged / officer: Chief Financial Officer

11/05/2025

Buy

$2.20

500,000

$1.100M

788,335

NASDAQ RLMD Relmada Therapeutics

Ence Chuck / officer: CAO and COO

11/05/2025

Buy

$2.20

136,000

$299K

403,931

NASDAQ RLMD Relmada Therapeutics

TRAVERSA SERGIO / director, officer: Chief Executive Officer

11/05/2025

Buy

$2.20

272,500

$600K

1.27M

NASDAQ RLMD Relmada Therapeutics

Kelly Paul Edward / director, officer: Chief Operating Officer

11/05/2025

Buy

$2.20

90,000

$198K

502,295